Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in refractory partial epilepsy
NCT00236730Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 1988
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of topiramate in focal epilepsy, sponsored by Johnson & Johnson. Started Jun 1988; status: completed.
02
Drugs
topiramate
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT00236730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236730.